#SarsCOV2

Eric Topol

EricTopol

When we don't measure important stuff.A thread about the immune response to #SARSCoV21. Since serology/IgG can be readily measured, this is what is conventionally used to assess an individual's responseThat's

Stuart Ray

soupvector

OP swab obtained in Milan #Italy on 5 Dec 2019 from a 4yo boy (measles suspected, d14 of Sx) positive for #SARSCoV2 RNA (GenBank https://www.ncbi.nlm.nih.gov/nuccore/MW303957). Lab reportedly SCV2-free, finding repeated,

Prof. Akiko Iwasaki

VirusesImmunity

Do some people have cross-reactive antibodies to #SARSCoV2? If so, who are they? And are these cross-reactive Abs protective against #COVID19? A fascinating study by @KevinWNg et al provides answers.

Prof Francois Balloux

BallouxFrancois

New preprint out. We investigated whether we could detect evidence for genetic recombination in #SARSCoV2, and found none to date. We used (slightly tweaked) standard statistical genetics methods, extensive simulations

Eric Feigl-Ding

DrEricDing

MINKS INFECT HUMANS. We know that for certain. Danish scientist say new #SARSCoV2 mutation mostly dodges our neutralizing antibodies, which is very bad. We should not yet panic, but the

Kulvinder Kaur MD

dockaurG

#FactsNotFear MUST WATCH: @FatEmperor's interview with Professor Emeritus of #Immunology Dr. Stadler of University of Bern in Switzerland.Dr. Stadler exposes #COVID19 fear-mongering and estimates ~70-80% of us already have T-cell

Prof Francois Balloux

BallouxFrancois

Many discussions about #COVID19 boil down to wether the virus is 'just like the flu' or 'nothing like the flu'. As such, I felt it may be useful to provide

Robin Monotti

robinmonotti

"HOSPITALS ARE OVERWHELMED" IS A BIG LIE. Hospitals are under-staffed on purpose by moving staff to needlessly administer SARSCoV2 viral fragment "testing" of healthy people with no disease, also known

Eric Topol

EricTopol

Connecting the dots between RSV, F, erection, S, and 2P's 1. The @McLellan_Lab work on RSV virus to stabilize the F protein (which may lead to successful vaccines)From https://www.newyorker.com/magazine/2021/01/04/the-plague-year @NewYo

Eric Topol

EricTopol

Our conversation with Tony Fauci was highly informative, and inspirational. A summary of key points of the podcast and commentary w/ @cuttingforstone @Medscape https://www.medscape.com/viewarticle/933619?src=soc_tw_200718_mscpedt_news_mdscp

Whitney R. Robinson

WhitneyEpi

Great demonstrating why I love science! Review of a new preprint finding (1) ~5% of popn has antibodies from virus infections that are cross-reactive to #SARSCoV2 but (2) these

Helen Branswell

HelenBranswell

1. Turning this into a brief thread. The prelim analysis — 90% efficacy — from the Pfizer #covid19 vaccine is very encouraging news re this vaccine AND....https://twitter.com/helenbranswell/status/1325771479003389954 2. It is

Interpolations

interpolated

Containment of COVID is a fool's errand. Why? In order for containment to work, it has to work everywhere. Not just in this or that neighborhood, but in all neighborhoods.

Prof Francois Balloux

BallouxFrancois

We previously inferred that none of the recurrent mutations observed in #SARSCoV2 is associated with higher transmission using the first ~47k genomes. Does N501Y, widely credited as the driver of

Ryan Pace

Dr_RyanPace

Ecstatic to share the first publication from our #breastfeeding #COVID19 studies https://mbio.asm.org/content/12/1/e03192-20 Important key points #humanmilk during #COVID19:is unlikely to contain #SARSCoV2contains anti-SARSCoV2 #antibodies

Prof Francois Balloux

BallouxFrancois

Paper out in Nature Comms. We developed a framework to analyse the contribution of #SARSCoV2 mutations to the virus' transmissibility. We applied it to nearly 50k genomes and we found

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.